-
Dear Doctor: Are scientists hiding viable treatments for cancer like ivermectin?
22 Sep 2025 13:20 GMT
… .
I am now on maintenance medications (Avastin and Lynparza). My numbers are … promising drugs turn out to be failures after the initial clinical trials … successful cancer treatments from being used. Having known many doctors and research …
-
Dr. Roach: Debunking ivermectin as a 'miracle treatment' for cancer
22 Sep 2025 13:24 GMT
… .
I am now on maintenance medications (Avastin and Lynparza). My numbers are … clinical trials.
There are people who feel that there are hidden treatments … successful cancer treatments from being used. Having known many doctors and research …
-
The FDA Grants BTD to R-DXd in Pretreated Gynecologic Cancers
16 Sep 2025 00:32 GMT
… previously treated with bevacizumab (Avastin), according to a press … Medical Oncology Gynecological Cancers Congress.2
“Patients have limited treatment … REJOICE-Ovarian01 Trial
This multicenter, randomized trial has an … by U.S. FDA for patients with CDH6 …
-
FDA Grants Breakthrough Status to Raludotatug Deruxtecan in Ovarian Cancer
15 Sep 2025 18:55 GMT
… .S. Food and Drug Administration (FDA) for the treatment of adult patients with … CDH6 who have received prior treatment with Avastin (bevacizumab).
“Patients have limited … 1 trial were first shared at the 2023 European Society for Medical …
-
FDA Grants Breakthrough Therapy Designation to R-DXd in Gynecologic Cancers
15 Sep 2025 17:57 GMT
… FDA has granted breakthrough therapy designation to the novel antibody-drug … who received prior treatment with bevacizumab (Avastin).1
The … conditions and fill unmet medical needs. The designation … Ovarian Cancer in Early Trial. News release. Daiichi …
-
<![CDATA[FDA Grants Breakthrough Therapy Designation to R-DXd in CDH6-Expressing Ovarian Cancer]]>
15 Sep 2025 22:47 GMT
… directed antibody-drug conjugate (ADC), for the treatment of … received prior treatment with bevacizumab (Avastin).1
The FDA’s decision … , randomized, open-label trial assessing the efficacy and … Clinical Development, and chief medical officer of MSD Research …
-
Garrett Eye Center has new treatment for eye problem
15 Sep 2025 08:02 GMT
… Mountain, offers many different treatment options for various eye conditions … stages, where there are fewer treatment options, he said.
“ … the time. But the FDA approved them because there’s … macular degeneration. One common medication is Avastin.
“That’s been a …
-
CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific
14 Sep 2025 12:19 GMT
… ), functional under the Central Drugs Standard Control Organization (CDSCO), … trial titled “A Phase 1, double-blind, randomized, two-treatment, … Pharmed., Iran comparing with Avastin 400 mg/16 … In 2004, bevacizumab gained FDA approval for specific types …
-
FDA Accepts New Drug Application for Relacorilant in Ovarian Cancer
11 Sep 2025 21:01 GMT
… and phase 2 clinical trials where patients who were … plus nab-paclitaxel and Avastin (bevacizumab) among patients … /fda-files-corcepts-new-drug-application-relacorilant-treatment-0
“ … -in-ovarian-cancer-trial
“BELLA Clinical Trial Initiated in Platinum- …
-
Relacorilant NDA Is Under FDA Review for Platinum-Resistant Ovarian Cancer
10 Sep 2025 23:13 GMT
… trial (NCT05257408), as well as data from phase 2 trials. Combined, these trials … , and had received prior treatment with bevacizumab (Avastin).2,3 Patients also … -details/fda-files-corcepts-new-drug-application-relacorilant-treatment-0
Olawaiye A …